Eight aromatic imine liquid crystalline (LC) diepoxides with dimeric architecture from readily available commercial reagents were synthesized and characterized by spectroscopic techniques. We characterized their liquid crystalline mesophases by differential scanning calorimetry (DSC), hot‐stage polarized‐light optical microscopy (POM) and wide‐angle X‐ray diffraction (WAXS). The mesomorphism of the products was related to their structure, which varies in the length of the central spacer. Odd‐membered spacer mesogens lead to the formation of smectic C mesophases, whereas even‐membered samples of this series lead to the formation of smectic A and/or nematic mesophases. By relating the calculated molecular parameters to the layer spacings obtained by WAXS, we deduced the organization of the mesogens in the smectic phases, since the dimeric compounds present a variety of possible arrangements. Liquid crystal thermosets (LCTs) were obtained from these monomers by isothermal curing with equimolar amounts of 2,4‐diaminotoluene (DAT). The curing process was studied by calorimetry and their thermal stability was evaluated by thermogravimetry (TGA). Most monomers produced nematic‐like networks, but in one case a smectic C mesophase was also locked.
Liquid crystalline thermosets (LCTs) were prepared by curing difunctional LC dimeric epoxy monomers with imine moieties in the mesogenic core and central spacers of different length. Primary diamines or tertiary amines were used as curing agents obtaining materials with different characteristics. The results obtained were related to the mesogen structure, since dipolar moments in the mesogenic cores affect the ability to form ordered networks.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.